Back
Repligen Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
61
RGEN
Repligen
Last Price:
143.23
Seasonality Move:
-3.11%
Buy
52
ANIP
ANI Pharmaceuticals
Last Price:
59.72
Seasonality Move:
0.29%
Buy
61
Repligen (RGEN)
is a Buy
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $145.78. The Score for RGEN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- RGEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $60.38. The Score for ANIP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $60.38
The current trend is relatively stagnant and ANIP is experiencing selling pressure, which indicates risk of future bearish movement.
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.09 | Sell |
| Relative Strength Index (14 RSI): | 50.4 | Buy |
| Chaikin Money Flow: | -350028 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (141.22 - 151.68) | Sell |
| Bollinger Bands (100): | (130.16 - 162.76) | Sell |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 50.97 | Buy |
| Chaikin Money Flow: | -160133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.9 - 62.96) | Sell |
| Bollinger Bands (100): | (59.68 - 65.4) | Sell |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 142.04 | Buy |
| 20-day SMA: | 144.7 | Buy |
| 50-day SMA: | 146.49 | Sell |
| 200-day SMA: | 164.76 | Sell |
| 8-day EMA: | 142.55 | Buy |
| 20-day EMA: | 144.83 | Buy |
| 50-day EMA: | 146.19 | Sell |
| 200-day EMA: | 156.5 | Sell |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.77 | Buy |
| 20-day SMA: | 60.29 | Buy |
| 50-day SMA: | 61.16 | Sell |
| 200-day SMA: | 61.28 | Sell |
| 8-day EMA: | 59.21 | Buy |
| 20-day EMA: | 59.69 | Buy |
| 50-day EMA: | 60.83 | Sell |
| 200-day EMA: | 60.53 | Sell |
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.27 per share, and an increase next year of $0.44 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.40 per share, an increase this year of $0.29 per share, and an increase next year of $0.98 per share.
Repligen Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||